Radiotherapy-induced anti-tumor immune response and immune-related adverse events in a case of recurrent nasopharyngeal carcinoma undergoing anti-PD-1 immunotherapy.
about
Radiotherapy-induced anti-tumor immune response and immune-related adverse events in a case of recurrent nasopharyngeal carcinoma undergoing anti-PD-1 immunotherapy.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Radiotherapy-induced anti-tumo ...... going anti-PD-1 immunotherapy.
@en
Radiotherapy-induced anti-tumo ...... going anti-PD-1 immunotherapy.
@nl
type
label
Radiotherapy-induced anti-tumo ...... going anti-PD-1 immunotherapy.
@en
Radiotherapy-induced anti-tumo ...... going anti-PD-1 immunotherapy.
@nl
prefLabel
Radiotherapy-induced anti-tumo ...... going anti-PD-1 immunotherapy.
@en
Radiotherapy-induced anti-tumo ...... going anti-PD-1 immunotherapy.
@nl
P2093
P2860
P50
P1433
P1476
Radiotherapy-induced anti-tumo ...... going anti-PD-1 immunotherapy.
@en
P2093
P2860
P2888
P356
10.1186/S12885-018-4295-8
P407
P577
2018-04-06T00:00:00Z
P6179
1103148618